Gritstone Oncology (GRTS) Presents At Biotechnology Conference - Slideshow

1 Corporate Presentation August 2019 Safe Harbor and Forward-Looking Statements This presentation contains forward-looking statements including, but not limited to, statements related to our preclinical and clinical product candidates, GRANITE, SLATE, and our bispecific antibody program. All statements other than statements of historical facts contained in this presentation, including statements regarding timing of patient enrollment in SLATE Phase 1, timing of immunogenicity and clinical data for GRANITE a ...